Li H - Search Results

1

3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Li M, Wu C, Yang Y, Zheng M, Yu S, Wang J, Chen L, Li H. Li M, et al. Among authors: li h. Cell Oncol (Dordr). 2021 Jun;44(3):541-556. doi: 10.1007/s13402-021-00599-9. Epub 2021 Mar 18. Cell Oncol (Dordr). 2021. PMID: 33735398 Review.

2

Withanolides from dietary tomatillo suppress HT1080 cancer cell growth by targeting mutant IDH1.

Yang Y, Xiang K, Sun D, Zheng M, Song Z, Li M, Wang X, Li H, Chen L. Yang Y, et al. Among authors: li h, li m. Bioorg Med Chem. 2021 Apr 15;36:116095. doi: 10.1016/j.bmc.2021.116095. Epub 2021 Feb 26. Bioorg Med Chem. 2021. PMID: 33735687

3

Novel PROTACs for degradation of SHP2 protein.

Zheng M, Liu Y, Wu C, Yang K, Wang Q, Zhou Y, Chen L, Li H. Zheng M, et al. Among authors: li h. Bioorg Chem. 2021 May;110:104788. doi: 10.1016/j.bioorg.2021.104788. Epub 2021 Mar 1. Bioorg Chem. 2021. PMID: 33706076

4

Discovery of metal-based complexes as promising antimicrobial agents.

Liang J, Sun D, Yang Y, Li M, Li H, Chen L. Liang J, et al. Among authors: li h, li m. Eur J Med Chem. 2021 Nov 15;224:113696. doi: 10.1016/j.ejmech.2021.113696. Epub 2021 Jul 8. Eur J Med Chem. 2021. PMID: 34274828 Review.

5

Discovery of linear unnatural peptides as potent mutant isocitrate dehydrogenase 1 inhibitors by Ugi reaction.

Zhou X, Zheng M, Zhao N, Hu Y, Yang K, Huo J, Liu G, Huang J, Chen L, Zhou Y, Li H. Zhou X, et al. Among authors: li h. Bioorg Chem. 2022 Feb;119:105569. doi: 10.1016/j.bioorg.2021.105569. Epub 2021 Dec 20. Bioorg Chem. 2022. PMID: 34954572

6

Glutamic oxaloacetic transaminase 1 as a potential target in human cancer.

Song Z, Yang Y, Wu Y, Zheng M, Sun D, Li H, Chen L. Song Z, et al. Among authors: li h. Eur J Pharmacol. 2022 Feb 15;917:174754. doi: 10.1016/j.ejphar.2022.174754. Epub 2022 Jan 8. Eur J Pharmacol. 2022. PMID: 35007521 Review.

7

Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.

Yang Y, Zheng M, Han F, Shang L, Li M, Gu X, Li H, Chen L. Yang Y, et al. Among authors: li h, li m. J Mol Med (Berl). 2022 Apr;100(4):599-612. doi: 10.1007/s00109-022-02181-8. Epub 2022 Feb 25. J Mol Med (Berl). 2022. PMID: 35212782

8

Entrectinib, a new multi-target inhibitor for cancer therapy.

Jiang Q, Li M, Li H, Chen L. Jiang Q, et al. Among authors: li h, li m. Biomed Pharmacother. 2022 Jun;150:112974. doi: 10.1016/j.biopha.2022.112974. Epub 2022 Apr 18. Biomed Pharmacother. 2022. PMID: 35447552 Free article. Review.

9

Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor.

Cheng L, Wu CR, Zhu LH, Li H, Chen LX. Cheng L, et al. Among authors: li h. Bioorg Med Chem Lett. 2017 Mar 1;27(5):1243-1246. doi: 10.1016/j.bmcl.2017.01.057. Epub 2017 Jan 21. Bioorg Med Chem Lett. 2017. PMID: 28174105

10

Withanolides isolated from Tubocapsicum anomalum and their antiproliferative activity.

Xiang K, Li C, Li MX, Song ZR, Ma XX, Sun DJ, Li H, Chen LX. Xiang K, et al. Among authors: li c, li h, li mx. Bioorg Chem. 2021 May;110:104809. doi: 10.1016/j.bioorg.2021.104809. Epub 2021 Mar 12. Bioorg Chem. 2021. PMID: 33752145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120,274 results

Search Page

Filters